← Master Registry

Published peptide research references

Melanotan II

Governed registry record

25 approved source records with original-source links. Source verification confirms the reference and its connection to this record; it does not certify every scientific conclusion or establish safety or efficacy.

Open the peptide evidence profile →

Approved source records

  1. Barbie drug identification: Not a child's play.

    Marine Deville; Corinne Charlier · Journal of forensic sciences · 2024

    DOI: 10.1111/1556-4029.15633PMID: 39302005

  2. PKC-α is involved in the signaling of phagocytosis induced by two snake venom secretory PLA2S in macrophages.

    Juliana Pavan Zuliani; Norma Yamanouye; José María Gutiérrez; Catarina Teixeira · Toxicon : official journal of the International Society on Toxinology · 2024

    DOI: 10.1016/j.toxicon.2024.107824PMID: 38908525

  3. Development of Ligand-Drug Conjugates Targeting Melanoma through the Overexpressed Melanocortin 1 Receptor.

    Yang Zhou; Saghar Mowlazadeh Haghighi; Zekun Liu; Lingzhi Wang; Victor J Hruby; Minying Cai · ACS pharmacology & translational science · 2020

    DOI: 10.1021/acs.jmedchem.8b00488PMID: 33073191

  4. Melanotan II: a possible cause of renal infarction: review of the literature and case report.

    Björn Peters; Henrik Hadimeri; Rebecka Wahlberg; Henri Afghahi · CEN case reports · 2020

    DOI: 10.1080/01926230601156237PMID: 31953620

  5. Metallothioneins regulate ATP7A trafficking and control cell viability during copper deficiency and excess.

    Nikita Gudekar; Vinit Shanbhag; Yanfang Wang; Martina Ralle; Gary A Weisman; Michael J Petris · Scientific reports · 2020

    DOI: 10.1073/pnas.1311749110PMID: 32398691

  6. Sites and sources of sympathoexcitation in obese male rats: role of brain insulin.

    Zhigang Shi; Ding Zhao; Priscila A Cassaglia; Virginia L Brooks · American journal of physiology. Regulatory, integrative and comparative physiology · 2020

    DOI: 10.1124/jpet.112.194738PMID: 31967846

  7. Metallothionein in Brain Disorders.

    Daniel Juárez-Rebollar; Camilo Rios; Concepción Nava-Ruíz; Marisela Méndez-Armenta · Oxidative medicine and cellular longevity · 2017

    DOI: 10.1016/j.jocn.2016.12.016PMID: 29085556

  8. 1,4-disubstituted-[1,2,3]triazolyl-containing analogues of MT-II: design, synthesis, conformational analysis, and biological activity.

    Chiara Testa; Mario Scrima; Manuela Grimaldi; Anna M D'Ursi; Marvin L Dirain; Nadège Lubin-Germain; Anamika Singh; Carrie Haskell-Luevano; Michael Chorev; Paolo Rovero; Anna M Papini · Journal of medicinal chemistry · 2014

    DOI: 10.1021/jm501027wPMID: 25347033

  9. Expression of metallothionein-I and II in skin ageing and its association with skin proliferation.

    C Ma; L-F Li; X Chen · The British journal of dermatology · 2011

    DOI: 10.1111/j.1365-2133.2010.10117.xPMID: 21054334

  10. Attenuation of cadmium-induced testicular injury in metallothionein-III null mice.

    Akiko Honda; Hiroaki Komuro; Akinori Shimada; Tatsuya Hasegawa; Yoshiyuki Seko; Hisamitsu Nagase; Isao Hozumi; Takashi Inuzuka; Hideaki Hara; Yasuyuki Fujiwara; Masahiko Satoh · Life sciences · 2010

    DOI: 10.1016/j.lfs.2010.09.009PMID: 20851133

  11. Development of high-fat-diet-induced obesity in female metallothionein-null mice.

    Masao Sato; Takashige Kawakami; Masuo Kondoh; Masufumi Takiguchi; Yoshito Kadota; Seiichiro Himeno; Shinya Suzuki · FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2010

    DOI: 10.1096/fj.09-145466PMID: 20219986

  12. Characterization of metallothioneins (MT-I and MT-II) in the yak.

    J P Wu; B Y Ma; H W Ren; L P Zhang; Y Xiang; M A Brown · Journal of animal science · 2007

    DOI: 10.2527/jas.2006-291PMID: 17121968

  13. The effects of the melanocortin agonist (MT-II) on subcutaneous and visceral adipose tissue in rodents.

    April D Strader; Haifei Shi; Ryuichi Ogawa; Randy J Seeley; Ofer Reizes · The Journal of pharmacology and experimental therapeutics · 2007

    DOI: 10.1124/jpet.107.123091PMID: 17567964

  14. Exercise-induced metallothionein expression in human skeletal muscle fibres.

    Milena Penkowa; Pernille Keller; Charlotte Keller; Juan Hidalgo; Mercedes Giralt; Bente Klarlund Pedersen · Experimental physiology · 2005

    DOI: 10.1113/expphysiol.2004.029371PMID: 15640275

  15. The role of MT in neurological disorders.

    Michael Aschner; Adrian K West · Journal of Alzheimer's disease : JAD · 2005

    DOI: 10.3233/jad-2005-8206PMID: 16308482

  16. MT-II induces penile erection via brain and spinal mechanisms.

    Hunter Wessells; Victor J Hruby; John Hackett; Guoxia Han; Preeti Balse-Srinivasan; Todd W Vanderah · Annals of the New York Academy of Sciences · 2003

    DOI: 10.1111/j.1749-6632.2003.tb03166.xPMID: 12851302

  17. Evidence for oligomerization of metallothioneins in their functional state.

    Tore W Wilhelmsen; Pål A Olsvik; Bjørn Henrik Hansen; Rolf A Andersen · Journal of chromatography. A · 2002

    DOI: 10.1016/s0021-9673(02)01259-1PMID: 12498255

  18. Expression of metallothionein isoforms in human chorioretinal complex.

    David J Tate; Michael V Miceli; David A Newsome · Current eye research · 2002

    DOI: 10.1076/ceyr.24.1.12.5426PMID: 12187490

  19. Regulation of metallothionein gene expression.

    K Ghoshal; S T Jacob · Progress in nucleic acid research and molecular biology · 2001

    DOI: 10.1016/s0079-6603(00)66034-8PMID: 11051769

  20. Cytoprotection by metallothionein against gastroduodenal mucosal injury caused by ethanol in mice.

    H Takano; M Satoh; A Shimada; M Sagai; T Yoshikawa; C Tohyama · Laboratory investigation; a journal of technical methods and pathology · 2000

    DOI: 10.1038/labinvest.3780041PMID: 10744072

  21. Radiation exposure does not alter metallothionein III isoform expression in mouse brain.

    S I Ono; L Cai; J Koropatnick; M G Cherian · Biological trace element research · 2000

    DOI: 10.1385/BTER:74:1:23PMID: 11049197

  22. Structure-function studies on the cyclic peptide MT-II, lactam derivative of alpha-melanotropin.

    M A Bednarek; M V Silva; B Arison; T MacNeil; R N Kalyani; R R Huang; D H Weinberg · Peptides · 1999

    DOI: 10.1016/s0196-9781(99)00048-0PMID: 10447101

  23. Metallothionein induction in neonatal rat primary astrocyte cultures protects against methylmercury cytotoxicity.

    L Rising; D Vitarella; H K Kimelberg; M Aschner · Journal of neurochemistry · 1995

    DOI: 10.1046/j.1471-4159.1995.65041562.xPMID: 7561850

  24. Human metallothionein MT-I and MT-II processed genes.

    U Varshney; L Gedamu · Gene · 1984

    DOI: 10.1016/0378-1119(84)90204-xPMID: 6526271

  25. Regulation, linkage, and sequence of mouse metallothionein I and II genes.

    P F Searle; B L Davison; G W Stuart; T M Wilkie; G Norstedt; R D Palmiter · Molecular and cellular biology · 1984

    DOI: 10.1128/mcb.4.7.1221-1230.1984PMID: 6095054